Approval · Notice of Compliance 27290 · 2021
POLIVY: Notice of Compliance 27290
Issued December 24, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
Issued with conditions (NOC/c): the company must confirm the benefit in further studies.
- Notice number
- 27290
- Date
- December 24, 2021
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Fulfillment of comment #3 of the Letter of Undertaking dated June 16, 2020
- With conditions
- Yes (NOC/c)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| POLIVY | Not yet assigned | — |
Medicinal ingredients
- POLATUZUMAB VEDOTIN 140 MG per VIAL